Takeda family preps for a last-stand vote against Shire buyout; Eli Lilly reportedly shopping drug portfolio in China
→ Kunio Takeda’s last shot at derailing Takeda’s $62 billion takeover of Shire will take place during the big shareholder vote coming up on December 5. The senior Takeda family member isn’t talking to the Financial Times this week, but he’s made his position known to others. “(H)e never imagined that the company would pursue such a radical form of globalisation,” one person close to Takeda told the FT. “He has recently expressed his views that he is against this deal.” It’s also unlikely he’ll have anything close to the votes needed to stop the acquisition, which gives CEO Christophe Weber the global operation he wanted to create.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.